Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...
In this lecture, economist Jeffrey Sachs explains how Asia’s rise since 1950 ended two centuries of Western economic ...
Proteases are naturally occurring enzymes that break down proteins into peptides and even single amino acids. They are useful ...
A laboratory shopping list can include a freezer, a case of pipette tips, a replacement milling jar, and a high-purity ...
The Defense Innovation Networking Group (D!NG) today announced that the submission window is officially open for the ...
Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.
How should investors think about the next phase of the AI investment cycle? In this NYSE Live interview, Sam Rahman, ...
Newspoint on MSN
Karnataka to develop framework for GCC-government collaboration on CSR: Priyank Kharge
Bengaluru: Karnataka will work towards developing a structured framework to facilitate collaboration between Global ...
The Telangana-Karnataka industrial partnership links Bengaluru’s design strength with Hyderabad’s manufacturing, biotech and ...
Microbiotica CEO Tim Sharpington spoke with Proactive's Stephen Gunnion about the company’s £36 million Series C funding round and plans to advance its lead treatment for ulcerative colitis into Phase ...
The country specializes in fragrance and skincare innovation, yet its counterparts in Korea and France get most of the global ...
In an industry-first convergence of quantum photonics and precision medicine, INmune Bio Inc. (NASDAQ: INMB) and Quantum Computing Inc. (NASDAQ: QUBT) have entered into a commercial collaboration to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results